Rated 3.8 / 5 (How Ratings Work)
Likely probability of the efficacy of cannabis for treatment of pain (due to advanced cancer).
Based on 8 Studies from 1975 - 2017
Study Name, Description & Year
Rating
Experts' Perspectives On The Role Of Medical Marijuana In Oncology: A Semistructured Interview Study
Review of 15 academic experts in the filed of oncology and medical cannabis interface. — 2017
Results Of A Double-Blind, Randomized, Placebo-Controlled Study Of Nabiximols Oromucosal Spray As Adjunctive Therapy In Advanced Cancer Patients With Chronic Uncontrolled Pain
Phase 3, double-blind, randomized, placebo-controlled trial in 397 patients with advanced cancer and average pain NRS scores ≥ 4 and ≤ 8 despite optimized opioid therapy. — 2017
β-caryophyllene And β-caryophyllene Oxide-natural Compounds Of Anticancer And Analgesic Properties
Review — 2016
Inhibitory CB1 And Activating/desensitizing TRPV1-mediated Cannabinoid Actions On CGRP Release In Rodent Skin.
Laboratory Study — 2011
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Of The Efficacy, Safety, And Tolerability Of THC:CBD Extract And THC Extract In Patients With Intractable Cancer-related Pain
Double-blind, placebo-controlled human study — 2010
Smoked Medicinal Cannabis For Neuropathic Pain In HIV: A Randomized, Crossover Clinical Trial
Double-blind, placebo-controlled, crossover human study — 2009
The Analgesic Properties Of Delta-9-tetrahydrocannabinol And Codeine
Human trial conducted on patients with cancer pains. — 1975